July 16, 2025- BD celebrated the 25th anniversary of BD ChloraPrep™ Skin Preparation solution at a celebration at its manufacturing facility.
Since BD ChloraPrep™ Skin Preparation gained initial U.S. Food and Drug Administration (FDA) approval on July 14, 2000, more than seven billion applicators have been distributed globally, and BD ChloraPrep™ Skin Preparation has become the most comprehensive chlorhexidine-alcohol (CHG/IPA) antiseptic skin prep portfolio for pre-surgical and preoperative applications to help reduce bacteria that potentially can cause skin infection.
“This anniversary is especially significant because BD ChloraPrep™ Skin Preparation has such a large positive impact on patients every day – from routine blood draws to lifesaving surgeries,” said Rian Seger, Worldwide president of BD Surgery. “This year alone, we project it will be used 18 times every second. Our team takes great pride and passion in ensuring BD ChloraPrep™ Skin Preparation continues to lead the industry in keeping patients safe with our unwavering commitment to quality and excellence as demonstrated by meeting the USP Monograph standard.”
BD ChloraPrep™ Skin Preparation has been trusted by healthcare providers for more than 25 years demonstrating category leadership through clinical evidence supported by more than 60 peer reviewed studies and is the only CHG/IPA portfolio with products for both pre-surgery and pre-operative procedures with demonstrated antimicrobial persistence for at least seven days. BD ChloraPrep™ Skin Preparation was the first to market with single-sterile applicators with its distinctive Hi-Lite Orange™ tint and the first sterile applicator with sterile solution in the US.